Sign In

Alexander (Sasha) Naydich

Director, Business Development & Corporate Strategy at Akamis Bio

Alexander (Sasha) Naydich is the Director of Business Development and Corporate Strategy at Akamis Bio, a biotechnology company focused on advancing innovative therapies. He is based in the New York City Metropolitan Area and has a strong background in bioengineering, particularly in new venture technology and strategy related to next-generation therapeutics.1

Naydich holds a degree from Harvard University, which underscores his academic credentials in the field.1 He has been active on LinkedIn, sharing insights about investments in biotechnology, such as recent activities involving the Myeloma Investment Fund and Nectin Therapeutics.2 With over 500 connections on LinkedIn, he is well-networked within the industry.1

Highlights

May 16 · linkedin

I'm excited to share MIF's investment in Nectin Therapeutics! Fabian Tenenbaum, Pini Tsukerman, and the Nectin team have demonstrated some exciting biology with multiple mechanisms of action driven by PVR blockade, and we look forward to exploring the applications of their first-in-class antibody as a therapy for multiple myeloma.

Dec 22 · linkedin

Very happy to share the MIF's recent new investments in Luminary Therapeutics, Inc, KAHR-Medical Ltd., and Telo Therapeutics, Inc. We're excited to support these three excellent teams in their work toward a cure for myeloma patients while further expanding the range of therapeutic technologies in MIF's portfolio.

Related Questions

What are Alexander (Sasha) Naydich's main responsibilities at Akamis Bio?
What is his educational background at Harvard University?
How has he contributed to the Myeloma Investment Fund?
What are some of his notable projects at Akamis Bio?
How does he leverage his bioengineering expertise in his role?
Alexander (Sasha) Naydich
Alexander (Sasha) Naydich, photo 1
Alexander (Sasha) Naydich, photo 2
Add to my network

Location

New York City Metropolitan Area